The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN).
The investment seeks long-term capital growth.
The fund seeks to achieve its objective by investing primarily in equity securities of issuers throughout the world. It seeks to diversify its portfolio broadly among developed and emerging countries and among multiple asset classes. Under normal market conditions, the fund invests at least 40% of its net assets in foreign assets. If market conditions are not deemed favorable by the Adviser, the fund could invest a lower percentage, but at least 30% of its net assets in foreign assets.
The average market capitalization across the Thrivent International Allocation A MF is 123.41B. The market cap for tickers in the group ranges from 3.51M to 271.34B. ASML holds the highest valuation in this group at 271.34B. The lowest valued company is NOVN at 3.51M.
The average weekly volume growth across all stocks in the Thrivent International Allocation A MF was -60%. For the same stocks of the MF, the average monthly volume growth was -64% and the average quarterly volume growth was -65%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 45
P/E Growth Rating: 39
Price Growth Rating: 48
SMR Rating: 54
Profit Risk Rating: 43
Seasonality Score: -12 (-100 ... +100)